The Impact of Traction Assisted ESD on Procedural Time and Outcome (ESD)

February 10, 2021 updated by: Region Skane

The Impact of Traction Assisted ESD on Procedural Time, En Bloc Resection, Curative Resection and Complication Incidence

The aim of this study is to evaluate the role of traction assisted ESD in comparison to traditional ESD on procedural time and outcome in patients with large, non pedunculated colorectal polyps.

Study Overview

Status

Withdrawn

Conditions

Detailed Description

Endoscopic polypectomy, has been proven to reduce Colorectal cancer incidence and mortality. Smaller lesions and pedunculated lesions can be removed by conventional polypectomy, Endoscopic mucosa resection (EMR). However, large sessile and flat lesions are difficult to remove En bloc with EMR, resulting in a high level of tumor recurrence. Endoscopic submucosal dissection (ESD) was developed during the 1990s in Japan to achieve En bloc resection of large neoplasms in the stomach but has in recent years also been extended into management of large (>2 cm) and technically challenging colorectal polyps. Large series on the efficacy of ESD in removing benign lesions show high En bloc resection rates resulting in low numbers of recurrences. Traction assisted ESD was developed in Japan to further improve the technique and reduce procedural time, the literature on the efficacy of traction assisted ESD is however scarce and limited to Japanese studies.

The aim in this study is to investigate the impact of this novel technique in comparison to traditional ESD on procedural time, En bloc resection rate, R0 resection rate and complication incidence.

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Skåne
      • Malmö, Skåne, Sweden
        • Skane University Hospitals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • > 2cm, flat or sessile colorectal polyp

Exclusion Criteria:

  • Recurrencies.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Traditional ESD
The patients in this Group will undergo traditional ESD.
Endoscopic submucosa dissection
EXPERIMENTAL: Traction assisted ESD
The patients in this Group will undergo traction assisted ESD
A clip attached to a thread is mounted on the lesion. Traction is achieved by pulling the thread during ESD

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Procedural time
Time Frame: 280 min, procedural time
Time consumption to complete the resection is measured.
280 min, procedural time

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
En bloc resection
Time Frame: 280 min, procedural time
En bloc resection rates will be recorded
280 min, procedural time
R0 resection
Time Frame: 4-8 weeks, when pathological examination is completed
R0 resection rate, stated in the pathology report will be recorded
4-8 weeks, when pathological examination is completed
Complication incidence
Time Frame: 2 weeks, when the timeframe for delayed complications is over.
All complications both immediate and delayed will be recorded
2 weeks, when the timeframe for delayed complications is over.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

January 8, 2018

Primary Completion (ANTICIPATED)

December 20, 2018

Study Completion (ANTICIPATED)

December 30, 2018

Study Registration Dates

First Submitted

May 30, 2017

First Submitted That Met QC Criteria

June 7, 2017

First Posted (ACTUAL)

June 8, 2017

Study Record Updates

Last Update Posted (ACTUAL)

February 15, 2021

Last Update Submitted That Met QC Criteria

February 10, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • CLIPTHREAD

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colorectal Polyp

Clinical Trials on Traditional ESD

Subscribe